Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
CDC slide shows 1,226 cases of myocarditis after mRNA vaccines » 11:33
06/23/21
06/23
11:33
06/23/21
11:33
PFE

Pfizer

$39.36 /

-0.24 (-0.61%)

, MRNA

Moderna

$215.02 /

-6.26 (-2.83%)

, BNTX

BioNTech

$231.27 /

-5.2 (-2.20%)

A Centers for Disease…

A Centers for Disease Control and Prevention presentation revealed that there have been more than 1,226 cases of myocarditis in people who received Pfizer's (PFE) or Moderna's (MRNA) Covid-19 vaccine. The agency's Advisory Committee on Immunization Practices is meeting to discuss reports of myocarditis or pericarditis in 16- to-24-year-olds after receiving the mRNA vaccines.

ShowHide Related Items >><<
PFE Pfizer
$39.36 /

-0.24 (-0.61%)

MRNA Moderna
$215.02 /

-6.26 (-2.83%)

BNTX BioNTech
$231.27 /

-5.2 (-2.20%)

PFE Pfizer
$39.36 /

-0.24 (-0.61%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
MRNA Moderna
$215.02 /

-6.26 (-2.83%)

06/22/21 Piper Sandler
Piper keeps $246 target on Moderna, sees 'several years' of Covid sales
06/16/21 Piper Sandler
Piper reiterates Overweight rating on Moderna after U.S. orders 200M more doses
06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
BNTX BioNTech
$231.27 /

-5.2 (-2.20%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
PFE Pfizer
$39.36 /

-0.24 (-0.61%)

MRNA Moderna
$215.02 /

-6.26 (-2.83%)

BNTX BioNTech
$231.27 /

-5.2 (-2.20%)

  • 23
    Jul
PFE Pfizer
$39.36 /

-0.24 (-0.61%)

MRNA Moderna
$215.02 /

-6.26 (-2.83%)

BNTX BioNTech
$231.27 /

-5.2 (-2.20%)

PFE Pfizer
$39.36 /

-0.24 (-0.61%)

MRNA Moderna
$215.02 /

-6.26 (-2.83%)

BNTX BioNTech
$231.27 /

-5.2 (-2.20%)

PFE Pfizer
$39.36 /

-0.24 (-0.61%)

MRNA Moderna
$215.02 /

-6.26 (-2.83%)

BNTX BioNTech
$231.27 /

-5.2 (-2.20%)

Tuesday
Conference/Events
SVB Leerink to hold a virtual forum » 04:55
06/22/21
06/22
04:55
06/22/21
04:55
ARCT

Arcturus Therapeutics

$32.71 /

-2.33 (-6.65%)

, BNTX

BioNTech

$225.61 /

+12.96 (+6.09%)

, CVAC

CureVac

$60.00 /

-2.22 (-3.57%)

, GNC

GNC Holdings

/

+

, GOVX

GeoVax Labs

$5.28 /

-0.09 (-1.68%)

, GRTX

Galera Therapeutics

$9.69 /

+0.5 (+5.44%)

, HOOK

Hookipa Pharma

$9.33 /

-0.1 (-1.06%)

, SNY

Sanofi

$52.58 /

-0.2 (-0.38%)

, TBIO

Translate Bio

$18.78 /

+0.45 (+2.45%)

, VXRT

Vaxart

$7.90 /

+0.07 (+0.89%)

Vaccine Virtual Forum…

Vaccine Virtual Forum will be held on June 21-22.

ShowHide Related Items >><<
VXRT Vaxart
$7.90 /

+0.07 (+0.89%)

TBIO Translate Bio
$18.78 /

+0.45 (+2.45%)

SNY Sanofi
$52.58 /

-0.2 (-0.38%)

HOOK Hookipa Pharma
$9.33 /

-0.1 (-1.06%)

GRTX Galera Therapeutics
$9.69 /

+0.5 (+5.44%)

GOVX GeoVax Labs
$5.28 /

-0.09 (-1.68%)

CVAC CureVac
$60.00 /

-2.22 (-3.57%)

BNTX BioNTech
$225.61 /

+12.96 (+6.09%)

ARCT Arcturus Therapeutics
$32.71 /

-2.33 (-6.65%)

ARCT Arcturus Therapeutics
$32.71 /

-2.33 (-6.65%)

06/21/21
Fly Intel: Top five analyst downgrades
06/21/21 Barclays
Arcturus Therapeutics downgraded to Underweight from Equal Weight at Barclays
06/18/21 Piper Sandler
CureVac data 'leaves the spot open' for Arcturus, says Piper Sandler
06/03/21 Baird
Arcturus Therapeutics transferred with Neutral at Baird
BNTX BioNTech
$225.61 /

+12.96 (+6.09%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
CVAC CureVac
$60.00 /

-2.22 (-3.57%)

06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Guggenheim
CureVac fair value drops to $15-$30 from $90-$110 after failure, says Guggenheim
GNC GNC Holdings
/

+

GOVX GeoVax Labs
$5.28 /

-0.09 (-1.68%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
GRTX Galera Therapeutics
$9.69 /

+0.5 (+5.44%)

04/26/21 Credit Suisse
Galera Therapeutics assumed with an Outperform at Credit Suisse
12/16/20 Credit Suisse
Galera Therapeutics upgraded to Outperform from Neutral at Credit Suisse
12/07/20 H.C. Wainwright
Galera Therapeutics initiated with a Buy at H.C. Wainwright
10/28/20 Citi
Galera Therapeutics price target raised to $21 from $18 at Citi
HOOK Hookipa Pharma
$9.33 /

-0.1 (-1.06%)

04/08/21 Morgan Stanley
Hookipa Pharma initiated with an Overweight at Morgan Stanley
11/30/20 JMP Securities
Hookipa Pharma price target raised to $25 from $19 at JMP Securities
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Truist
Hookipa Pharma initiated with a Buy at Truist
SNY Sanofi
$52.58 /

-0.2 (-0.38%)

05/25/21 JPMorgan
Olema selloff brings 'compelling' entry point, says JPMorgan
04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
TBIO Translate Bio
$18.78 /

+0.45 (+2.45%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
Translate Bio downgraded to Market Perform from Outperform at SVB Leerink
03/18/21 Roth Capital
Translate Bio price target lowered to $28 from $37 at Roth Capital
VXRT Vaxart
$7.90 /

+0.07 (+0.89%)

06/11/21
Fly Intel: Top five analyst initiations
06/11/21 Piper Sandler
Vaxart initiated with an Overweight at Piper Sandler
03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
VXRT Vaxart
$7.90 /

+0.07 (+0.89%)

TBIO Translate Bio
$18.78 /

+0.45 (+2.45%)

SNY Sanofi
$52.58 /

-0.2 (-0.38%)

HOOK Hookipa Pharma
$9.33 /

-0.1 (-1.06%)

GRTX Galera Therapeutics
$9.69 /

+0.5 (+5.44%)

BNTX BioNTech
$225.61 /

+12.96 (+6.09%)

ARCT Arcturus Therapeutics
$32.71 /

-2.33 (-6.65%)

  • 28
    Jan
  • 09
    Dec
  • 08
    Dec
  • 25
    Sep
  • 14
    Aug
  • 29
    Jul
  • 23
    Jul
  • 26
    Jun
SNY Sanofi
$52.58 /

-0.2 (-0.38%)

CVAC CureVac
$60.00 /

-2.22 (-3.57%)

BNTX BioNTech
$225.61 /

+12.96 (+6.09%)

VXRT Vaxart
$7.90 /

+0.07 (+0.89%)

TBIO Translate Bio
$18.78 /

+0.45 (+2.45%)

SNY Sanofi
$52.58 /

-0.2 (-0.38%)

CVAC CureVac
$60.00 /

-2.22 (-3.57%)

BNTX BioNTech
$225.61 /

+12.96 (+6.09%)

ARCT Arcturus Therapeutics
$32.71 /

-2.33 (-6.65%)

VXRT Vaxart
$7.90 /

+0.07 (+0.89%)

CVAC CureVac
$60.00 /

-2.22 (-3.57%)

BNTX BioNTech
$225.61 /

+12.96 (+6.09%)

ARCT Arcturus Therapeutics
$32.71 /

-2.33 (-6.65%)

Monday
Conference/Events
SVB Leerink to hold a virtual forum » 10:04
06/21/21
06/21
10:04
06/21/21
10:04
ARCT

Arcturus Therapeutics

$32.28 /

-2.76 (-7.88%)

, BNTX

BioNTech

$220.02 /

+7.37 (+3.47%)

, CVAC

CureVac

$59.89 /

-2.335 (-3.75%)

, GNC

GNC Holdings

/

+

, GOVX

GeoVax Labs

$5.35 /

-0.02 (-0.37%)

, GRTX

Galera Therapeutics

$9.09 /

-0.1 (-1.09%)

, HOOK

Hookipa Pharma

$9.30 /

-0.13 (-1.38%)

, SNY

Sanofi

$52.56 /

-0.22 (-0.42%)

, TBIO

Translate Bio

$18.13 /

-0.2 (-1.09%)

, VXRT

Vaxart

$7.67 /

-0.16 (-2.04%)

Vaccine Virtual Forum…

Vaccine Virtual Forum will be held on June 21-22.

ShowHide Related Items >><<
VXRT Vaxart
$7.67 /

-0.16 (-2.04%)

TBIO Translate Bio
$18.13 /

-0.2 (-1.09%)

SNY Sanofi
$52.56 /

-0.22 (-0.42%)

HOOK Hookipa Pharma
$9.30 /

-0.13 (-1.38%)

GRTX Galera Therapeutics
$9.09 /

-0.1 (-1.09%)

GOVX GeoVax Labs
$5.35 /

-0.02 (-0.37%)

CVAC CureVac
$59.89 /

-2.335 (-3.75%)

BNTX BioNTech
$220.02 /

+7.37 (+3.47%)

ARCT Arcturus Therapeutics
$32.28 /

-2.76 (-7.88%)

ARCT Arcturus Therapeutics
$32.28 /

-2.76 (-7.88%)

06/21/21
Fly Intel: Top five analyst downgrades
06/21/21 Barclays
Arcturus Therapeutics downgraded to Underweight from Equal Weight at Barclays
06/18/21 Piper Sandler
CureVac data 'leaves the spot open' for Arcturus, says Piper Sandler
06/03/21 Baird
Arcturus Therapeutics transferred with Neutral at Baird
BNTX BioNTech
$220.02 /

+7.37 (+3.47%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
CVAC CureVac
$59.89 /

-2.335 (-3.75%)

06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Guggenheim
CureVac fair value drops to $15-$30 from $90-$110 after failure, says Guggenheim
GNC GNC Holdings
/

+

GOVX GeoVax Labs
$5.35 /

-0.02 (-0.37%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
GRTX Galera Therapeutics
$9.09 /

-0.1 (-1.09%)

04/26/21 Credit Suisse
Galera Therapeutics assumed with an Outperform at Credit Suisse
12/16/20 Credit Suisse
Galera Therapeutics upgraded to Outperform from Neutral at Credit Suisse
12/07/20 H.C. Wainwright
Galera Therapeutics initiated with a Buy at H.C. Wainwright
10/28/20 Citi
Galera Therapeutics price target raised to $21 from $18 at Citi
HOOK Hookipa Pharma
$9.30 /

-0.13 (-1.38%)

04/08/21 Morgan Stanley
Hookipa Pharma initiated with an Overweight at Morgan Stanley
11/30/20 JMP Securities
Hookipa Pharma price target raised to $25 from $19 at JMP Securities
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Truist
Hookipa Pharma initiated with a Buy at Truist
SNY Sanofi
$52.56 /

-0.22 (-0.42%)

05/25/21 JPMorgan
Olema selloff brings 'compelling' entry point, says JPMorgan
04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
TBIO Translate Bio
$18.13 /

-0.2 (-1.09%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
Translate Bio downgraded to Market Perform from Outperform at SVB Leerink
03/18/21 Roth Capital
Translate Bio price target lowered to $28 from $37 at Roth Capital
VXRT Vaxart
$7.67 /

-0.16 (-2.04%)

06/11/21
Fly Intel: Top five analyst initiations
06/11/21 Piper Sandler
Vaxart initiated with an Overweight at Piper Sandler
03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
VXRT Vaxart
$7.67 /

-0.16 (-2.04%)

TBIO Translate Bio
$18.13 /

-0.2 (-1.09%)

SNY Sanofi
$52.56 /

-0.22 (-0.42%)

HOOK Hookipa Pharma
$9.30 /

-0.13 (-1.38%)

GRTX Galera Therapeutics
$9.09 /

-0.1 (-1.09%)

BNTX BioNTech
$220.02 /

+7.37 (+3.47%)

ARCT Arcturus Therapeutics
$32.28 /

-2.76 (-7.88%)

  • 28
    Jan
  • 09
    Dec
  • 08
    Dec
  • 25
    Sep
  • 14
    Aug
  • 29
    Jul
  • 23
    Jul
  • 26
    Jun
SNY Sanofi
$52.56 /

-0.22 (-0.42%)

CVAC CureVac
$59.89 /

-2.335 (-3.75%)

BNTX BioNTech
$220.02 /

+7.37 (+3.47%)

VXRT Vaxart
$7.67 /

-0.16 (-2.04%)

TBIO Translate Bio
$18.13 /

-0.2 (-1.09%)

SNY Sanofi
$52.56 /

-0.22 (-0.42%)

CVAC CureVac
$59.89 /

-2.335 (-3.75%)

BNTX BioNTech
$220.02 /

+7.37 (+3.47%)

ARCT Arcturus Therapeutics
$32.28 /

-2.76 (-7.88%)

VXRT Vaxart
$7.67 /

-0.16 (-2.04%)

CVAC CureVac
$59.89 /

-2.335 (-3.75%)

BNTX BioNTech
$220.02 /

+7.37 (+3.47%)

ARCT Arcturus Therapeutics
$32.28 /

-2.76 (-7.88%)

Friday
Hot Stocks
BioNTech doses first patient in BNT111 cancer vaccine trial » 05:05
06/18/21
06/18
05:05
06/18/21
05:05
BNTX

BioNTech

$214.27 /

+10.19 (+4.99%)

BioNTech announced that…

BioNTech announced that the first patient has been treated in its BNT111 Phase 2 cancer vaccine trial. The study is evaluating the company's therapeutic cancer vaccine candidate BNT111 in combination with Libtayo in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma. BNT111 is the lead product candidate from BioNTech's FixVac platform that targets a fixed combination of mRNA-encoded, tumor-associated antigens with the objective of triggering a strong and precise immune response against cancer and is fully owned by BioNTech.

ShowHide Related Items >><<
BNTX BioNTech
$214.27 /

+10.19 (+4.99%)

BNTX BioNTech
$214.27 /

+10.19 (+4.99%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
BNTX BioNTech
$214.27 /

+10.19 (+4.99%)

  • 23
    Jul
BNTX BioNTech
$214.27 /

+10.19 (+4.99%)

BNTX BioNTech
$214.27 /

+10.19 (+4.99%)

BNTX BioNTech
$214.27 /

+10.19 (+4.99%)

Over a week ago
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:33
06/16/21
06/16
16:33
06/16/21
16:33
AMZN

Amazon.com

$3,415.77 /

+33.75 (+1.00%)

, WKHS

Workhorse Group

$14.89 /

+0.72 (+5.08%)

, GM

General Motors

$61.75 /

+0.94 (+1.55%)

, F

Ford

$15.02 /

+0.015 (+0.10%)

, ELAN

Elanco

$36.00 /

+1.17 (+3.36%)

, KIN

Kindred Biosciences

$9.24 /

+2.89 (+45.51%)

, APO

Apollo Global

$58.57 /

+0.57 (+0.98%)

, VIAV

Viavi

$17.78 /

+0.32 (+1.83%)

, EXFO

Exfo

$6.04 /

+0.105 (+1.77%)

, DISH

Dish

$41.19 /

+1.03 (+2.56%)

, CCL

Carnival

$29.28 /

+0.665 (+2.32%)

, RCL

Royal Caribbean

$88.56 /

+1.68 (+1.93%)

, NCLH

Norwegian Cruise Line

$31.69 /

+0.84 (+2.72%)

, BNTX

BioNTech

$203.89 /

-14.09 (-6.46%)

, MAXR

Maxar Technologies

$39.99 /

+3.99 (+11.08%)

, OSK

Oshkosh

$125.09 /

-2.25 (-1.77%)

, CVS

CVS Health

$84.73 /

-0.68 (-0.80%)

, LUV

Southwest

$56.67 /

-0.46 (-0.81%)

, JNJ

Johnson & Johnson

$164.37 /

-0.13 (-0.08%)

, FB

Facebook

$331.09 /

-5.57 (-1.65%)

, RUN

Sunrun

$47.75 /

+4.58 (+10.61%)

, MNKD

MannKind

$4.33 /

+0.22 (+5.35%)

, UTHR

United Therapeutics

$183.46 /

+4.66 (+2.61%)

, GOED

1847 Goedeker

$3.22 /

+0.15 (+4.89%)

, TAL

TAL Education

$24.00 /

-4.85 (-16.81%)

, RBLX

Roblox

$82.55 /

-7.21 (-8.03%)

, ORCL

Oracle

$77.07 /

-4.57 (-5.60%)

, LZB

La-Z-Boy

$37.34 /

-5.01 (-11.83%)

, FRPT

Freshpet

$163.26 /

-1.84 (-1.11%)

, NUE

Nucor

$99.92 /

-1.99 (-1.95%)

, CNC

Centene

$72.62 /

+2.61 (+3.73%)

Get caught up quickly on…

ShowHide Related Items >><<
WKHS Workhorse Group
$14.89 /

+0.72 (+5.08%)

VIAV Viavi
$17.78 /

+0.32 (+1.83%)

UTHR United Therapeutics
$183.46 /

+4.66 (+2.61%)

TAL TAL Education
$24.00 /

-4.85 (-16.81%)

RUN Sunrun
$47.75 /

+4.58 (+10.61%)

RCL Royal Caribbean
$88.56 /

+1.68 (+1.93%)

RBLX Roblox
$82.55 /

-7.21 (-8.03%)

OSK Oshkosh
$125.09 /

-2.25 (-1.77%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$99.92 /

-1.99 (-1.95%)

NCLH Norwegian Cruise Line
$31.69 /

+0.84 (+2.72%)

MNKD MannKind
$4.33 /

+0.22 (+5.35%)

MAXR Maxar Technologies
$39.99 /

+3.99 (+11.08%)

LZB La-Z-Boy
$37.34 /

-5.01 (-11.83%)

LUV Southwest
$56.67 /

-0.46 (-0.81%)

JNJ Johnson & Johnson
$164.37 /

-0.13 (-0.08%)

GOED 1847 Goedeker
$3.22 /

+0.15 (+4.89%)

GM General Motors
$61.75 /

+0.94 (+1.55%)

FRPT Freshpet
$163.26 /

-1.84 (-1.11%)

FB Facebook
$331.09 /

-5.57 (-1.65%)

F Ford
$15.02 /

+0.015 (+0.10%)

EXFO Exfo
$6.04 /

+0.105 (+1.77%)

ELAN Elanco
$36.00 /

+1.17 (+3.36%)

DISH Dish
$41.19 /

+1.03 (+2.56%)

CVS CVS Health
$84.73 /

-0.68 (-0.80%)

CNC Centene
$72.62 /

+2.61 (+3.73%)

CCL Carnival
$29.28 /

+0.665 (+2.32%)

BNTX BioNTech
$203.89 /

-14.09 (-6.46%)

APO Apollo Global
$58.57 /

+0.57 (+0.98%)

AMZN Amazon.com
$3,415.77 /

+33.75 (+1.00%)

AMZN Amazon.com
$3,415.77 /

+33.75 (+1.00%)

06/16/21 JPMorgan
JPMorgan values Amazon Prime at $1,000 per year, 8.5 times actual price
06/16/21 Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/16/21 Pivotal Research
Dish upgraded to Buy from Hold at Pivotal Research
06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
WKHS Workhorse Group
$14.89 /

+0.72 (+5.08%)

06/08/21 Colliers
California HVIP vouchers 'an important development' for EV stocks, says Colliers
06/04/21
Fly Intel: Top five analyst downgrades
06/04/21 Cowen
Workhorse Group downgraded to Market Perform from Outperform at Cowen
05/11/21 B. Riley
B. Riley cuts Workhorse target but says earnings selloff overblown
GM General Motors
$61.75 /

+0.94 (+1.55%)

06/16/21 Citi
Citi sees path to over $100 per share for GM after guidance and EV spending hike
06/07/21 Barclays
General Motors price target raised to $70 from $66 at Barclays
06/04/21 JPMorgan
General Motors price target raised to $73 from $71 at JPMorgan
06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
F Ford
$15.02 /

+0.015 (+0.10%)

06/04/21 JPMorgan
Ford price target raised to $18 from $16 at JPMorgan
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 Jefferies
Ford 'playing to its strengths' with new EV strategy, says Jefferies
ELAN Elanco
$36.00 /

+1.17 (+3.36%)

06/17/21 H.C. Wainwright
Kindred Biosciences downgraded to Neutral from Buy at H.C. Wainwright
06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
KIN Kindred Biosciences
$9.24 /

+2.89 (+45.51%)

06/16/21 Aegis
Kindred Biosciences downgraded to Hold from Buy at Aegis
06/16/21 Aegis
Kindred Biosciences downgraded to Hold from Buy at Aegis
05/12/21 Alliance Global Partners
Kindred Biosciences price target raised to $15.25 from $9.25 at Alliance Global
APO Apollo Global
$58.57 /

+0.57 (+0.98%)

06/14/21 Citi
Athene Holding price target raised to $66 from $54 at Citi
05/14/21 Truist
Athene Holding price target raised to $68 from $56 at Truist
05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/10/21 Citi
Citi boosts Apollo target to $72, opens 'Positive Catalyst Watch'
VIAV Viavi
$17.78 /

+0.32 (+1.83%)

02/03/21 B. Riley
Viavi price target raised to $20 from $19 at B. Riley Securities
02/01/21 B. Riley
Viavi price target raised to $19 from $18 at B. Riley Securities
01/26/21 MKM Partners
Viavi resumed with a Buy at MKM Partners
09/11/20 B. Riley
Viavi pullback a buying opportunity, says B. Riley FBR
EXFO Exfo
$6.04 /

+0.105 (+1.77%)

06/08/21 Canaccord
Exfo price target raised to $6 from $4 at Canaccord
06/08/21 Northland
Exfo price target raised to $7.25 from $6 at Northland
01/13/21 BMO Capital
Exfo price target raised to C$4 from C$3.75 at BMO Capital
07/09/20 B. Riley
EXFO results positive for Viavi and Dasan, says B. Riley FBR
DISH Dish
$41.19 /

+1.03 (+2.56%)

06/16/21
Fly Intel: Top five analyst upgrades
06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
CCL Carnival
$29.28 /

+0.665 (+2.32%)

06/16/21 Wolfe Research
Wolfe upgrades 'Big 3' cruise stocks on improving booking momentum
06/16/21 Wolfe Research
Carnival upgraded to Outperform from Peer Perform at Wolfe Research
06/11/21 Credit Suisse
Royal Caribbean selloff on Covid cases an opportunity, says Credit Suisse
06/11/21 Argus
Carnival price target raised to $35 from $33 at Argus
RCL Royal Caribbean
$88.56 /

+1.68 (+1.93%)

06/16/21 Wolfe Research
Royal Caribbean upgraded to Outperform from Peer Perform at Wolfe Research
04/29/21 William Blair
Royal Caribbean March bookings on par with 2019 peak wave, says William Blair
NCLH Norwegian Cruise Line
$31.69 /

+0.84 (+2.72%)

06/16/21 Wolfe Research
Norwegian Cruise upgraded to Outperform from Peer Perform at Wolfe Research
06/09/21 Stifel
Norwegian Cruise Line price target raised to $40 from $37 at Stifel
BNTX BioNTech
$203.89 /

-14.09 (-6.46%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
MAXR Maxar Technologies
$39.99 /

+3.99 (+11.08%)

06/16/21
Fly Intel: Top five analyst initiations
06/16/21 Goldman Sachs
Maxar Technologies initiated with a Buy at Goldman Sachs
05/04/21 JPMorgan
Maxar Technologies positive outlook intact despite miss, says JPMorgan
04/05/21 TD Securities
TD upgrades Maxar Technologies on 'compelling' entry after selloff
OSK Oshkosh
$125.09 /

-2.25 (-1.77%)

06/04/21 Baird
DOD deal shows Oshkosh more active M&A strategy paying dividends, says Baird
05/12/21 Evercore ISI
Oshkosh price target raised to $166 from $133 at Evercore ISI
04/29/21 KeyBanc
Oshkosh price target raised to $140 from $133 at KeyBanc
04/29/21 Credit Suisse
Oshkosh price target raised to $154 from $138 at Credit Suisse
CVS CVS Health
$84.73 /

-0.68 (-0.80%)

05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
05/26/21 Deutsche Bank
Amazon unlikely to enter retail pharmacy business, says Deutsche Bank
05/19/21 BMO Capital
CVS Health price target raised to $96 from $90 at BMO Capital
05/19/21 Barclays
CVS Health price target raised to $100 from $92 at Barclays
LUV Southwest
$56.67 /

-0.46 (-0.81%)

06/09/21 MKM Partners
Southwest initiated with a Buy at MKM Partners
04/15/21 Barclays
Southwest price target raised to $64 from $51 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
JNJ Johnson & Johnson
$164.37 /

-0.13 (-0.08%)

06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
FB Facebook
$331.09 /

-5.57 (-1.65%)

06/08/21 Tigress Financial
Tigress sees Facebook shares going to $430 within 12 months
06/08/21 Wedbush
Apple WWDC 'all about iOS 15, new Macs,' says Wedbush
06/03/21 Jefferies
Facebook building 'comprehensive SMB tool-set,' says Jefferies
06/03/21 Wedbush
Wedbush expects data privacy to be main focus of Apple's Cook keynote address
RUN Sunrun
$47.75 /

+4.58 (+10.61%)

06/16/21 Morgan Stanley
Sunrun price target raised to $91 from $86 at Morgan Stanley
06/02/21 Guggenheim
Sunrun assumed with a Buy at Guggenheim
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
05/07/21 Truist
Sunrun price target lowered to $81 from $95 at Truist
MNKD MannKind
$4.33 /

+0.22 (+5.35%)

05/13/21 RBC Capital
MannKind initiated with a Sector Perform at RBC Capital
02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
UTHR United Therapeutics
$183.46 /

+4.66 (+2.61%)

05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
04/26/21 Credit Suisse
United Therapeutics assumed with an Outperform at Credit Suisse
04/08/21 JPMorgan
United Therapeutics price target raised to $212 from $185 at JPMorgan
02/25/21 Wedbush
United Therapeutics price target raised to $260 from $255 at Wedbush
GOED 1847 Goedeker
$3.22 /

+0.15 (+4.89%)

TAL TAL Education
$24.00 /

-4.85 (-16.81%)

06/16/21 Morgan Stanley
TAL Education cut to Underweight on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
New Oriental Education downgraded on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
TAL Education downgraded to Underweight from Overweight at Morgan Stanley
06/11/21 Citi
Citi double downgrades Gaotu Techedu to Sell on Chinese regulation risk
RBLX Roblox
$82.55 /

-7.21 (-8.03%)

06/16/21 Truist
Truist says May typically a down month for Roblox, June expected higher
06/16/21 Morgan Stanley
Morgan Stanley lowers Q2 estimates for Roblox, says long-term view unchanged
06/16/21 JPMorgan
Roblox shares likely range-bound after May metrics, says JPMorgan
06/16/21 Stifel
Roblox May KPIs 'probably not enough' to sustain shares' momentum, says Stifel
ORCL Oracle
$77.07 /

-4.57 (-5.60%)

06/16/21 Morgan Stanley
Oracle shares likely range-bound until visibility improves, says Morgan Stanley
06/16/21 Jefferies
Oracle price target raised to $80 from $75 at Jefferies
06/16/21 Monness Crespi
Monness Crespi would be buyers of Oracle on any post-earnings weakness
06/16/21 JPMorgan
Oracle price target raised to $77 from $73 at JPMorgan
LZB La-Z-Boy
$37.34 /

-5.01 (-11.83%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
FRPT Freshpet
$163.26 /

-1.84 (-1.11%)

06/14/21 Baird
Freshpet recall not symptomatic of systemic issue, says Baird
06/09/21 Jefferies
Chewy addition unlocks significant opportunity for Freshpet, says Jefferies
06/09/21 Oppenheimer
Oppenheimer views Freshpet partnership with Chewy 'very favorably'
05/25/21 Baird
Baird finds sign that Freshpet launch on Chewy.com looks 'imminent'
NUE Nucor
$99.92 /

-1.99 (-1.95%)

06/16/21 JPMorgan
Nucor initiated with a Neutral at JPMorgan
06/10/21 GLJ Research
GLJ ups U.S. Steel target, says valuation 'materially below reality'
05/14/21 BMO Capital
Nucor price target raised to $110 from $86 at BMO Capital
04/20/21
Fly Intel: Top five analyst upgrades
CNC Centene
$72.62 /

+2.61 (+3.73%)

06/17/21 Mizuho
Centene price target raised to $75 from $65 at Mizuho
06/17/21 Citi
Centene price target raised to $86 from $80 at Citi
06/08/21 BofA
Centene price target raised to $85 from $75 at BofA
05/18/21 Wells Fargo
Centene initiated with an Overweight at Wells Fargo
WKHS Workhorse Group
$14.89 /

+0.72 (+5.08%)

VIAV Viavi
$17.78 /

+0.32 (+1.83%)

UTHR United Therapeutics
$183.46 /

+4.66 (+2.61%)

TAL TAL Education
$24.00 /

-4.85 (-16.81%)

RUN Sunrun
$47.75 /

+4.58 (+10.61%)

RCL Royal Caribbean
$88.56 /

+1.68 (+1.93%)

RBLX Roblox
$82.55 /

-7.21 (-8.03%)

OSK Oshkosh
$125.09 /

-2.25 (-1.77%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$99.92 /

-1.99 (-1.95%)

NCLH Norwegian Cruise Line
$31.69 /

+0.84 (+2.72%)

MNKD MannKind
$4.33 /

+0.22 (+5.35%)

MAXR Maxar Technologies
$39.99 /

+3.99 (+11.08%)

LZB La-Z-Boy
$37.34 /

-5.01 (-11.83%)

LUV Southwest
$56.67 /

-0.46 (-0.81%)

KIN Kindred Biosciences
$9.24 /

+2.89 (+45.51%)

JNJ Johnson & Johnson
$164.37 /

-0.13 (-0.08%)

GM General Motors
$61.75 /

+0.94 (+1.55%)

FRPT Freshpet
$163.26 /

-1.84 (-1.11%)

FB Facebook
$331.09 /

-5.57 (-1.65%)

F Ford
$15.02 /

+0.015 (+0.10%)

EXFO Exfo
$6.04 /

+0.105 (+1.77%)

ELAN Elanco
$36.00 /

+1.17 (+3.36%)

DISH Dish
$41.19 /

+1.03 (+2.56%)

CVS CVS Health
$84.73 /

-0.68 (-0.80%)

CNC Centene
$72.62 /

+2.61 (+3.73%)

CCL Carnival
$29.28 /

+0.665 (+2.32%)

BNTX BioNTech
$203.89 /

-14.09 (-6.46%)

APO Apollo Global
$58.57 /

+0.57 (+0.98%)

AMZN Amazon.com
$3,415.77 /

+33.75 (+1.00%)

  • 28
    May
  • 18
    Mar
  • 05
    Mar
  • 01
    Mar
  • 24
    Feb
  • 23
    Feb
  • 01
    Dec
  • 18
    Nov
  • 12
    Nov
  • 21
    Oct
  • 14
    Oct
  • 13
    Oct
  • 31
    Jul
  • 23
    Jul
  • 17
    Jul
WKHS Workhorse Group
$14.89 /

+0.72 (+5.08%)

RCL Royal Caribbean
$88.56 /

+1.68 (+1.93%)

RBLX Roblox
$82.55 /

-7.21 (-8.03%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$99.92 /

-1.99 (-1.95%)

LUV Southwest
$56.67 /

-0.46 (-0.81%)

JNJ Johnson & Johnson
$164.37 /

-0.13 (-0.08%)

GM General Motors
$61.75 /

+0.94 (+1.55%)

FRPT Freshpet
$163.26 /

-1.84 (-1.11%)

FB Facebook
$331.09 /

-5.57 (-1.65%)

F Ford
$15.02 /

+0.015 (+0.10%)

ELAN Elanco
$36.00 /

+1.17 (+3.36%)

DISH Dish
$41.19 /

+1.03 (+2.56%)

CVS CVS Health
$84.73 /

-0.68 (-0.80%)

CNC Centene
$72.62 /

+2.61 (+3.73%)

CCL Carnival
$29.28 /

+0.665 (+2.32%)

BNTX BioNTech
$203.89 /

-14.09 (-6.46%)

APO Apollo Global
$58.57 /

+0.57 (+0.98%)

AMZN Amazon.com
$3,415.77 /

+33.75 (+1.00%)

WKHS Workhorse Group
$14.89 /

+0.72 (+5.08%)

VIAV Viavi
$17.78 /

+0.32 (+1.83%)

UTHR United Therapeutics
$183.46 /

+4.66 (+2.61%)

TAL TAL Education
$24.00 /

-4.85 (-16.81%)

RUN Sunrun
$47.75 /

+4.58 (+10.61%)

RBLX Roblox
$82.55 /

-7.21 (-8.03%)

OSK Oshkosh
$125.09 /

-2.25 (-1.77%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

MAXR Maxar Technologies
$39.99 /

+3.99 (+11.08%)

LZB La-Z-Boy
$37.34 /

-5.01 (-11.83%)

LUV Southwest
$56.67 /

-0.46 (-0.81%)

KIN Kindred Biosciences
$9.24 /

+2.89 (+45.51%)

JNJ Johnson & Johnson
$164.37 /

-0.13 (-0.08%)

GOED 1847 Goedeker
$3.22 /

+0.15 (+4.89%)

GM General Motors
$61.75 /

+0.94 (+1.55%)

FRPT Freshpet
$163.26 /

-1.84 (-1.11%)

FB Facebook
$331.09 /

-5.57 (-1.65%)

F Ford
$15.02 /

+0.015 (+0.10%)

EXFO Exfo
$6.04 /

+0.105 (+1.77%)

ELAN Elanco
$36.00 /

+1.17 (+3.36%)

DISH Dish
$41.19 /

+1.03 (+2.56%)

CVS CVS Health
$84.73 /

-0.68 (-0.80%)

CNC Centene
$72.62 /

+2.61 (+3.73%)

CCL Carnival
$29.28 /

+0.665 (+2.32%)

BNTX BioNTech
$203.89 /

-14.09 (-6.46%)

APO Apollo Global
$58.57 /

+0.57 (+0.98%)

AMZN Amazon.com
$3,415.77 /

+33.75 (+1.00%)

WKHS Workhorse Group
$14.89 /

+0.72 (+5.08%)

TAL TAL Education
$24.00 /

-4.85 (-16.81%)

RUN Sunrun
$47.75 /

+4.58 (+10.61%)

RCL Royal Caribbean
$88.56 /

+1.68 (+1.93%)

RBLX Roblox
$82.55 /

-7.21 (-8.03%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$99.92 /

-1.99 (-1.95%)

NCLH Norwegian Cruise Line
$31.69 /

+0.84 (+2.72%)

MNKD MannKind
$4.33 /

+0.22 (+5.35%)

LUV Southwest
$56.67 /

-0.46 (-0.81%)

JNJ Johnson & Johnson
$164.37 /

-0.13 (-0.08%)

GM General Motors
$61.75 /

+0.94 (+1.55%)

FB Facebook
$331.09 /

-5.57 (-1.65%)

F Ford
$15.02 /

+0.015 (+0.10%)

DISH Dish
$41.19 /

+1.03 (+2.56%)

CVS CVS Health
$84.73 /

-0.68 (-0.80%)

CNC Centene
$72.62 /

+2.61 (+3.73%)

CCL Carnival
$29.28 /

+0.665 (+2.32%)

BNTX BioNTech
$203.89 /

-14.09 (-6.46%)

APO Apollo Global
$58.57 /

+0.57 (+0.98%)

AMZN Amazon.com
$3,415.77 /

+33.75 (+1.00%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:09
06/16/21
06/16
12:09
06/16/21
12:09
GM

General Motors

$62.21 /

+1.4 (+2.30%)

, F

Ford

$15.08 /

+0.08 (+0.53%)

, ELAN

Elanco

$35.95 /

+1.12 (+3.22%)

, KIN

Kindred Biosciences

$9.20 /

+2.85 (+44.88%)

, AMZN

Amazon.com

$3,398.69 /

+16.67 (+0.49%)

, APO

Apollo Global

$58.54 /

+0.54 (+0.93%)

, RBLX

Roblox

$84.38 /

-5.38 (-5.99%)

, VIAV

Viavi

$17.98 /

+0.52 (+2.98%)

, EXFO

Exfo

$6.92 /

+0.985 (+16.60%)

, KO

Coca-Cola

$55.02 /

-0.405 (-0.73%)

, WKHS

Workhorse Group

$15.43 /

+1.265 (+8.93%)

, OSK

Oshkosh

$126.18 /

-1.16 (-0.91%)

, CVS

CVS Health

$85.85 /

+0.44 (+0.52%)

, KKR

KKR

$56.49 /

+0.8 (+1.44%)

, LUV

Southwest

$57.46 /

+0.33 (+0.58%)

, RUN

Sunrun

$48.51 /

+5.34 (+12.37%)

, MNKD

MannKind

$4.41 /

+0.3 (+7.30%)

, UTHR

United Therapeutics

$184.32 /

+5.52 (+3.09%)

, GOED

1847 Goedeker

$3.34 /

+0.27 (+8.79%)

, TAL

TAL Education

$25.17 /

-3.68 (-12.76%)

, RAPT

Rapt Therapeutics

$32.84 /

-2.12 (-6.06%)

, ORCL

Oracle

$77.07 /

-4.57 (-5.60%)

, LZB

La-Z-Boy

$38.10 /

-4.25 (-10.04%)

, FRPT

Freshpet

$164.18 /

-0.92 (-0.56%)

, NUE

Nucor

$100.95 /

-0.96 (-0.94%)

, CNC

Centene

$74.10 /

+4.09 (+5.84%)

, DISH

Dish

$41.66 /

+1.5 (+3.74%)

, CCL

Carnival

$29.36 /

+0.745 (+2.60%)

, RCL

Royal Caribbean

$88.91 /

+2.03 (+2.34%)

, NCLH

Norwegian Cruise Line

$31.68 /

+0.83 (+2.69%)

, BNTX

BioNTech

$203.67 /

-14.31 (-6.56%)

, MAXR

Maxar Technologies

$41.55 /

+5.55 (+15.42%)

Get caught up quickly on…

ShowHide Related Items >><<
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

VIAV Viavi
$17.98 /

+0.52 (+2.98%)

UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MNKD MannKind
$4.41 /

+0.3 (+7.30%)

MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

GOED 1847 Goedeker
$3.34 /

+0.27 (+8.79%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

EXFO Exfo
$6.92 /

+0.985 (+16.60%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

06/16/21 Citi
Citi sees path to over $100 per share for GM after guidance and EV spending hike
06/07/21 Barclays
General Motors price target raised to $70 from $66 at Barclays
06/04/21 JPMorgan
General Motors price target raised to $73 from $71 at JPMorgan
06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
F Ford
$15.08 /

+0.08 (+0.53%)

06/04/21 JPMorgan
Ford price target raised to $18 from $16 at JPMorgan
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 Jefferies
Ford 'playing to its strengths' with new EV strategy, says Jefferies
ELAN Elanco
$35.95 /

+1.12 (+3.22%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
KIN Kindred Biosciences
$9.20 /

+2.85 (+44.88%)

06/16/21 Aegis
Kindred Biosciences downgraded to Hold from Buy at Aegis
06/16/21 Aegis
Kindred Biosciences downgraded to Hold from Buy at Aegis
05/12/21 Alliance Global Partners
Kindred Biosciences price target raised to $15.25 from $9.25 at Alliance Global
12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

06/16/21 JPMorgan
JPMorgan values Amazon Prime at $1,000 per year, 8.5 times actual price
06/16/21 Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/16/21 Pivotal Research
Dish upgraded to Buy from Hold at Pivotal Research
06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
APO Apollo Global
$58.54 /

+0.54 (+0.93%)

06/14/21 Citi
Athene Holding price target raised to $66 from $54 at Citi
05/14/21 Truist
Athene Holding price target raised to $68 from $56 at Truist
05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/10/21 Citi
Citi boosts Apollo target to $72, opens 'Positive Catalyst Watch'
RBLX Roblox
$84.38 /

-5.38 (-5.99%)

06/16/21 Truist
Truist says May typically a down month for Roblox, June expected higher
06/16/21 Morgan Stanley
Morgan Stanley lowers Q2 estimates for Roblox, says long-term view unchanged
06/16/21 JPMorgan
Roblox shares likely range-bound after May metrics, says JPMorgan
06/16/21 Stifel
Roblox May KPIs 'probably not enough' to sustain shares' momentum, says Stifel
VIAV Viavi
$17.98 /

+0.52 (+2.98%)

02/03/21 B. Riley
Viavi price target raised to $20 from $19 at B. Riley Securities
02/01/21 B. Riley
Viavi price target raised to $19 from $18 at B. Riley Securities
01/26/21 MKM Partners
Viavi resumed with a Buy at MKM Partners
09/11/20 B. Riley
Viavi pullback a buying opportunity, says B. Riley FBR
EXFO Exfo
$6.92 /

+0.985 (+16.60%)

06/08/21 Canaccord
Exfo price target raised to $6 from $4 at Canaccord
06/08/21 Northland
Exfo price target raised to $7.25 from $6 at Northland
01/13/21 BMO Capital
Exfo price target raised to C$4 from C$3.75 at BMO Capital
07/09/20 B. Riley
EXFO results positive for Viavi and Dasan, says B. Riley FBR
KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

06/15/21 Credit Suisse
Coca-Cola price target raised to $62 from $60 at Credit Suisse
06/04/21 Morgan Stanley
Coca-Cola price target raised to $64 from $60 at Morgan Stanley
05/14/21 Wells Fargo
Wells says Coca-Cola Energy discontinuation may 'rekindle' Monster M&A debate
05/14/21 Evercore ISI
Coke Energy discontinuation a 'small positive' for Monster, says Evercore ISI
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

06/08/21 Colliers
California HVIP vouchers 'an important development' for EV stocks, says Colliers
06/04/21
Fly Intel: Top five analyst downgrades
06/04/21 Cowen
Workhorse Group downgraded to Market Perform from Outperform at Cowen
05/11/21 B. Riley
B. Riley cuts Workhorse target but says earnings selloff overblown
OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

06/04/21 Baird
DOD deal shows Oshkosh more active M&A strategy paying dividends, says Baird
05/12/21 Evercore ISI
Oshkosh price target raised to $166 from $133 at Evercore ISI
04/29/21 KeyBanc
Oshkosh price target raised to $140 from $133 at KeyBanc
04/29/21 Credit Suisse
Oshkosh price target raised to $154 from $138 at Credit Suisse
CVS CVS Health
$85.85 /

+0.44 (+0.52%)

05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
05/26/21 Deutsche Bank
Amazon unlikely to enter retail pharmacy business, says Deutsche Bank
05/19/21 BMO Capital
CVS Health price target raised to $96 from $90 at BMO Capital
05/19/21 Barclays
CVS Health price target raised to $100 from $92 at Barclays
KKR KKR
$56.49 /

+0.8 (+1.44%)

05/05/21 Credit Suisse
KKR price target raised to $66 from $60 at Credit Suisse
05/05/21 Deutsche Bank
KKR price target raised to $60 from $52 at Deutsche Bank
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/14/21 BMO Capital
KKR price target raised to $71 from $69 at BMO Capital
LUV Southwest
$57.46 /

+0.33 (+0.58%)

06/09/21 MKM Partners
Southwest initiated with a Buy at MKM Partners
04/15/21 Barclays
Southwest price target raised to $64 from $51 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
RUN Sunrun
$48.51 /

+5.34 (+12.37%)

06/16/21 Morgan Stanley
Sunrun price target raised to $91 from $86 at Morgan Stanley
06/02/21 Guggenheim
Sunrun assumed with a Buy at Guggenheim
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
05/07/21 Truist
Sunrun price target lowered to $81 from $95 at Truist
MNKD MannKind
$4.41 /

+0.3 (+7.30%)

05/13/21 RBC Capital
MannKind initiated with a Sector Perform at RBC Capital
02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
04/26/21 Credit Suisse
United Therapeutics assumed with an Outperform at Credit Suisse
04/08/21 JPMorgan
United Therapeutics price target raised to $212 from $185 at JPMorgan
02/25/21 Wedbush
United Therapeutics price target raised to $260 from $255 at Wedbush
GOED 1847 Goedeker
$3.34 /

+0.27 (+8.79%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

06/16/21 Morgan Stanley
TAL Education cut to Underweight on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
New Oriental Education downgraded on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
TAL Education downgraded to Underweight from Overweight at Morgan Stanley
06/11/21 Citi
Citi double downgrades Gaotu Techedu to Sell on Chinese regulation risk
RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
ORCL Oracle
$77.07 /

-4.57 (-5.60%)

06/16/21 Morgan Stanley
Oracle shares likely range-bound until visibility improves, says Morgan Stanley
06/16/21 Jefferies
Oracle price target raised to $80 from $75 at Jefferies
06/16/21 Monness Crespi
Monness Crespi would be buyers of Oracle on any post-earnings weakness
06/16/21 JPMorgan
Oracle price target raised to $77 from $73 at JPMorgan
LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

06/14/21 Baird
Freshpet recall not symptomatic of systemic issue, says Baird
06/09/21 Jefferies
Chewy addition unlocks significant opportunity for Freshpet, says Jefferies
06/09/21 Oppenheimer
Oppenheimer views Freshpet partnership with Chewy 'very favorably'
05/25/21 Baird
Baird finds sign that Freshpet launch on Chewy.com looks 'imminent'
NUE Nucor
$100.95 /

-0.96 (-0.94%)

06/16/21 JPMorgan
Nucor initiated with a Neutral at JPMorgan
06/10/21 GLJ Research
GLJ ups U.S. Steel target, says valuation 'materially below reality'
05/14/21 BMO Capital
Nucor price target raised to $110 from $86 at BMO Capital
04/20/21
Fly Intel: Top five analyst upgrades
CNC Centene
$74.10 /

+4.09 (+5.84%)

06/08/21 BofA
Centene price target raised to $85 from $75 at BofA
05/18/21 Wells Fargo
Centene initiated with an Overweight at Wells Fargo
05/11/21 BMO Capital
Centene price target raised to $88 from $77 at BMO Capital
05/11/21 Stephens
Centene upgraded to Overweight following underperformance at Stephens
DISH Dish
$41.66 /

+1.5 (+3.74%)

06/16/21
Fly Intel: Top five analyst upgrades
06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
CCL Carnival
$29.36 /

+0.745 (+2.60%)

06/16/21 Wolfe Research
Wolfe upgrades 'Big 3' cruise stocks on improving booking momentum
06/16/21 Wolfe Research
Carnival upgraded to Outperform from Peer Perform at Wolfe Research
06/11/21 Credit Suisse
Royal Caribbean selloff on Covid cases an opportunity, says Credit Suisse
06/11/21 Argus
Carnival price target raised to $35 from $33 at Argus
RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

06/16/21 Wolfe Research
Royal Caribbean upgraded to Outperform from Peer Perform at Wolfe Research
04/29/21 William Blair
Royal Caribbean March bookings on par with 2019 peak wave, says William Blair
NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

06/16/21 Wolfe Research
Norwegian Cruise upgraded to Outperform from Peer Perform at Wolfe Research
06/09/21 Stifel
Norwegian Cruise Line price target raised to $40 from $37 at Stifel
BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

06/16/21
Fly Intel: Top five analyst initiations
06/16/21 Goldman Sachs
Maxar Technologies initiated with a Buy at Goldman Sachs
05/04/21 JPMorgan
Maxar Technologies positive outlook intact despite miss, says JPMorgan
04/05/21 TD Securities
TD upgrades Maxar Technologies on 'compelling' entry after selloff
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

VIAV Viavi
$17.98 /

+0.52 (+2.98%)

UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MNKD MannKind
$4.41 /

+0.3 (+7.30%)

MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

KIN Kindred Biosciences
$9.20 /

+2.85 (+44.88%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

EXFO Exfo
$6.92 /

+0.985 (+16.60%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

  • 16
    Jun
  • 28
    May
  • 18
    Mar
  • 05
    Mar
  • 01
    Mar
  • 24
    Feb
  • 23
    Feb
  • 01
    Dec
  • 18
    Nov
  • 12
    Nov
  • 11
    Nov
  • 21
    Oct
  • 14
    Oct
  • 13
    Oct
  • 31
    Jul
  • 23
    Jul
  • 17
    Jul
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

VIAV Viavi
$17.98 /

+0.52 (+2.98%)

UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

KIN Kindred Biosciences
$9.20 /

+2.85 (+44.88%)

GOED 1847 Goedeker
$3.34 /

+0.27 (+8.79%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

EXFO Exfo
$6.92 /

+0.985 (+16.60%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MNKD MannKind
$4.41 /

+0.3 (+7.30%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

F Ford
$15.08 /

+0.08 (+0.53%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

Periodicals
Pfizer sees return to normal by end of 2022, CEO tells CNBC » 11:54
06/16/21
06/16
11:54
06/16/21
11:54
PFE

Pfizer

$39.69 /

+0.09 (+0.23%)

, BNTX

BioNTech

$202.25 /

-15.73 (-7.22%)

Pfizer (PFE) CEO Albert…

Pfizer (PFE) CEO Albert Bourla told CNBC on Wednesday that he expects life could return to normal for developed countries by the end of this year and the rest of the world by the end of 2022, as there should be enough Covid-19 vaccine doses for most world leaders to successfully inoculate their populations against the virus. "I think the whole world will have enough volumes by the end of 2022 to vaccinate, to protect everyone," he said. "And I think that by the end of this year, the developed world will already be in this situation." Pfizer and BioNTech (BNTX) hit the milestone of manufacturing 1 billion doses of their Covid vaccine last week, Bourla added. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

PFE Pfizer
$39.69 /

+0.09 (+0.23%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

  • 23
    Jul
PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:53
06/16/21
06/16
09:53
06/16/21
09:53
BNTX

BioNTech

$209.08 /

-8.9 (-4.08%)

, X

U.S. Steel

$25.95 /

-0.99 (-3.67%)

, NSIT

Insight Enterprises

$103.26 /

-3.28 (-3.08%)

, SAGE

Sage Therapeutics

$57.61 /

-1.4 (-2.37%)

, RMD

ResMed

$234.62 /

-1.715 (-0.73%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BioNTech (BNTX) downgraded to Sell from Neutral at Redburn with analyst Simon Baker saying the share gains since the end of March factor in more than the increase in value implied by recent guidance upgrades and revenue expectations for its Covid-19 vaccine. 2. U.S. Steel (X) downgraded to Underweight from Neutral at JPMorgan with analyst Michael Glick saying he is taking a "barbell approach" to his ratings, and cites the stock's outperformance year-to-date, lower out-year free cash flow, and "clunkier" asset base relative to Cliffs for the downgrade. 3. Insight Enterprises (NSIT) downgraded to Neutral from Overweight at JPMorgan with analyst Paul Coster citing valuation for the downgrade with the shares up 40% year-to-date and 110% year-over-year. 4. Sage Therapeutics (SAGE) downgraded to Market Perform from Outperform at William Blair with analyst Tim Lugo saying the data from the WATERFALL study support registration, but show a marginal benefit for zuranolone at the 50 mg dose, which could limit the commercial opportunity for the product and will likely lead to payer pushback. 5. ResMed (RMD) downgraded to Underperform from Neutral at BofA with analyst Lyanne Harrison believing that the market has over-reacted on positive side to a competitor's product recall and cites valuation for the rating change with shares trading at an all-time high price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
X U.S. Steel
$25.95 /

-0.99 (-3.67%)

SAGE Sage Therapeutics
$57.61 /

-1.4 (-2.37%)

NSIT Insight Enterprises
$103.26 /

-3.28 (-3.08%)

BNTX BioNTech
$209.08 /

-8.9 (-4.08%)

BNTX BioNTech
$209.08 /

-8.9 (-4.08%)

06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
X U.S. Steel
$25.95 /

-0.99 (-3.67%)

06/16/21 JPMorgan
U.S. Steel assumed with Underweight from Neutral at JPMorgan
06/10/21 GLJ Research
GLJ ups U.S. Steel target, says valuation 'materially below reality'
06/04/21
Fly Intel: Top five analyst upgrades
06/04/21 UBS
U.S. Steel upgraded to Neutral from Sell at UBS
NSIT Insight Enterprises
$103.26 /

-3.28 (-3.08%)

06/16/21 JPMorgan
Insight Enterprises downgraded to Neutral on valuation at JPMorgan
06/16/21 JPMorgan
Insight Enterprises downgraded to Neutral from Overweight at JPMorgan
05/07/21 Barrington
Insight Enterprises price target raised to $110 from $102 at Barrington
02/12/21 Barrington
Insight Enterprises price target raised to $102 from $72 at Barrington
SAGE Sage Therapeutics
$57.61 /

-1.4 (-2.37%)

06/16/21 Truist
Sage Therapeutics price target lowered to $60 from $70 at Truist
06/16/21 Stifel
Sage Therapeutics price target lowered to $95 from $121 at Stifel
06/16/21 William Blair
Sage Therapeutics downgraded to Market Perform from Outperform at William Blair
06/16/21 BMO Capital
Sage Therapeutics price target lowered to $73 from $87 at BMO Capital
RMD ResMed
$234.62 /

-1.715 (-0.73%)

06/16/21 BofA
ResMed downgraded to Underperform from Neutral at BofA
06/15/21 Oppenheimer
ResMed price target raised to $270 from $240 at Oppenheimer
06/09/21 CLSA
ResMed upgraded to Outperform from Sell at CLSA
05/21/21 JPMorgan
ResMed upgraded to Overweight from Neutral at JPMorgan
X U.S. Steel
$25.95 /

-0.99 (-3.67%)

SAGE Sage Therapeutics
$57.61 /

-1.4 (-2.37%)

RMD ResMed
$234.62 /

-1.715 (-0.73%)

NSIT Insight Enterprises
$103.26 /

-3.28 (-3.08%)

BNTX BioNTech
$209.08 /

-8.9 (-4.08%)

  • 03
    Feb
  • 23
    Jul
  • 18
    Jun
X U.S. Steel
$25.95 /

-0.99 (-3.67%)

BNTX BioNTech
$209.08 /

-8.9 (-4.08%)

X U.S. Steel
$25.95 /

-0.99 (-3.67%)

SAGE Sage Therapeutics
$57.61 /

-1.4 (-2.37%)

BNTX BioNTech
$209.08 /

-8.9 (-4.08%)

X U.S. Steel
$25.95 /

-0.99 (-3.67%)

RMD ResMed
$234.62 /

-1.715 (-0.73%)

BNTX BioNTech
$209.08 /

-8.9 (-4.08%)

On The Fly
Fly Intel: Pre-market Movers » 08:53
06/16/21
06/16
08:53
06/16/21
08:53
SPI

SPI Energy

$6.57 /

-0.19 (-2.81%)

, KIN

Kindred Biosciences

$6.35 /

+0.31 (+5.13%)

, ELAN

Elanco

$34.83 /

+1.33 (+3.97%)

, MNKD

MannKind

$4.11 /

-0.02 (-0.48%)

, ARVL

Arrival

$19.90 /

+1.14 (+6.08%)

, FORD

Forward Industries

$2.73 /

-0.15 (-5.21%)

, CNTG

Centogene

$10.25 /

-0.31 (-2.94%)

, ORCL

Oracle

$81.64 /

-0.95 (-1.15%)

, MX

MagnaChip

$25.64 /

-0.2 (-0.77%)

, BNTX

BioNTech

$217.98 /

-2 (-0.91%)

, IKT

Inhibikase Therapeutics

$4.03 /

-0.825 (-16.99%)

, RBLX

Roblox

$89.80 /

+2.02 (+2.30%)

Check out this morning's…

ShowHide Related Items >><<
SPI SPI Energy
$6.57 /

-0.19 (-2.81%)

RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

MX MagnaChip
$25.64 /

-0.2 (-0.77%)

MNKD MannKind
$4.11 /

-0.02 (-0.48%)

KIN Kindred Biosciences
$6.35 /

+0.31 (+5.13%)

IKT Inhibikase Therapeutics
$4.03 /

-0.825 (-16.99%)

FORD Forward Industries
$2.73 /

-0.15 (-5.21%)

CNTG Centogene
$10.25 /

-0.31 (-2.94%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

ARVL Arrival
$19.90 /

+1.14 (+6.08%)

SPI SPI Energy
$6.57 /

-0.19 (-2.81%)

KIN Kindred Biosciences
$6.35 /

+0.31 (+5.13%)

05/12/21 Alliance Global Partners
Kindred Biosciences price target raised to $15.25 from $9.25 at Alliance Global
12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
12/18/20 Alliance Global Partners
Kindred Biosciences price target lowered to $9.25 from $10.25 at Alliance Global Partners
12/14/20 Lake Street
Kindred Biosciences struck 'terrific arrangement' with Elanco, says Lake Street
ELAN Elanco
$34.83 /

+1.33 (+3.97%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
MNKD MannKind
$4.11 /

-0.02 (-0.48%)

05/13/21 RBC Capital
MannKind initiated with a Sector Perform at RBC Capital
02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
ARVL Arrival
$19.90 /

+1.14 (+6.08%)

06/03/21 Barclays
Arrival initiated with an Overweight at Barclays
04/05/21 Cowen
Cowen starts Arrival at Outperform on 'unique microfactory approach'
04/05/21 Cowen
Arrival initiated with an Outperform at Cowen
FORD Forward Industries
$2.73 /

-0.15 (-5.21%)

CNTG Centogene
$10.25 /

-0.31 (-2.94%)

11/05/20 Credit Suisse
Centogene initiated with an Outperform at Credit Suisse
ORCL Oracle
$81.64 /

-0.95 (-1.15%)

06/16/21 Morgan Stanley
Oracle shares likely range-bound until visibility improves, says Morgan Stanley
06/16/21 Jefferies
Oracle price target raised to $80 from $75 at Jefferies
06/16/21 Monness Crespi
Monness Crespi would be buyers of Oracle on any post-earnings weakness
06/16/21 JPMorgan
Oracle price target raised to $77 from $73 at JPMorgan
MX MagnaChip
$25.64 /

-0.2 (-0.77%)

03/30/21 Vertical Group
MagnaChip downgraded to Neutral from Buy at Vertical Group
03/04/21 Needham
Needham revises view on MagnaChip SOTP value to $41-$46 per share
03/04/21 Needham
MagnaChip could be worth $39-$45 per share in a deal, says Needham
02/23/21 Citi
MagnaChip price target raised to $20 from $19 at Citi
BNTX BioNTech
$217.98 /

-2 (-0.91%)

06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
IKT Inhibikase Therapeutics
$4.03 /

-0.825 (-16.99%)

04/26/21 ThinkEquity
Inhibikase Therapeutics initiated with a Buy at ThinkEquity
RBLX Roblox
$89.80 /

+2.02 (+2.30%)

06/16/21 Morgan Stanley
Morgan Stanley lowers Q2 estimates for Roblox, says long-term view unchanged
06/16/21 JPMorgan
Roblox shares likely range-bound after May metrics, says JPMorgan
06/16/21 Stifel
Roblox May KPIs 'probably not enough' to sustain shares' momentum, says Stifel
06/01/21 Truist
Roblox price target raised to $103 from $83 at Truist
RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

MX MagnaChip
$25.64 /

-0.2 (-0.77%)

MNKD MannKind
$4.11 /

-0.02 (-0.48%)

KIN Kindred Biosciences
$6.35 /

+0.31 (+5.13%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

CNTG Centogene
$10.25 /

-0.31 (-2.94%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

  • 16
    Jun
  • 01
    Dec
  • 28
    Oct
  • 01
    Oct
  • 23
    Jul
  • 10
    Jul
RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

ARVL Arrival
$19.90 /

+1.14 (+6.08%)

SPI SPI Energy
$6.57 /

-0.19 (-2.81%)

RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

MX MagnaChip
$25.64 /

-0.2 (-0.77%)

KIN Kindred Biosciences
$6.35 /

+0.31 (+5.13%)

IKT Inhibikase Therapeutics
$4.03 /

-0.825 (-16.99%)

FORD Forward Industries
$2.73 /

-0.15 (-5.21%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

ARVL Arrival
$19.90 /

+1.14 (+6.08%)

SPI SPI Energy
$6.57 /

-0.19 (-2.81%)

RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

MNKD MannKind
$4.11 /

-0.02 (-0.48%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

ARVL Arrival
$19.90 /

+1.14 (+6.08%)

Downgrade
BioNTech downgraded to Sell from Neutral at Redburn » 05:05
06/16/21
06/16
05:05
06/16/21
05:05
BNTX

BioNTech

$217.98 /

-2 (-0.91%)

Redburn analyst Simon…

Redburn analyst Simon Baker downgraded BioNTech to Sell from Neutral with a fair value estimate of $146. The share gains since the end of March factor in more than the increase in value implied by recent guidance upgrades and revenue expectations for its Covid-19 vaccine, Baker tells investors in a research note. The analyst views BioNTech's valuation as high and awaits a better entry point.

ShowHide Related Items >><<
BNTX BioNTech
$217.98 /

-2 (-0.91%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
BNTX BioNTech
$217.98 /

-2 (-0.91%)

  • 23
    Jul
BNTX BioNTech
$217.98 /

-2 (-0.91%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

BNTX BioNTech
$217.98 /

-2 (-0.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.